Toh Han Chong

Dr. Toh is Deputy Medical Director, National Cancer Centre Singapore (NCCS), Associate Professor at the Cancer & Stem Cell Biology Program, Duke-NUS and PI at the Singapore Immunology Network.

Dr. Toh graduated from the University of London, UK, with an Intercalated Bachelor of Science in ‘Infection and Immunity’ from St Mary’s Hospital Medical School and qualified as a medical doctor from University of Cambridge, United Kingdom. Dr. Toh obtained his Fellowship of the Royal College of Physicians in 2003. He received his medical oncology fellowship training at the Singapore General Hospital, and at the Massachusetts General Hospital, Harvard Medical School, Boston, USA. He then completed a research fellowship in cancer immunotherapy at the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA. He is a graduate of the General Management Program at Harvard Business School.

Dr. Toh received the National Outstanding Clinician Scientist Award 2018 and has published over 100 peer-review journal articles. He is the founding chairman of the Singapore Cancer Immunotherapy Consortium, a member of the World Immunotherapy Council, and on the Cancer Immunotherapy faculty of the European Society of Medical Oncology.